CD8A and neoplasm: When vaccinated with P2Et-pretreated 4T1 cells, the primary tumor growth was improved by yielding IL-2, TNFα, IL-4, IL-5, and IFNγ-producing CD4+ and CD8+ T lymphocytes [191].